GLPwatch
Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
NCT01507337 · Completed
Last updated 2026-05-28This clinical trial compares how the diabetes medication liraglutide is processed in the body by healthy young adults versus healthy older adults.
Status Completed The study has finished.
Phase Phase 1 Checks safety and dosing in a small group.
Type Interventional (clinical trial)
Design Non-randomized, open-label (no blinding) treatment study
Participants 32 people
Who can join Ages 18+ · all sexes Healthy volunteers accepted.
Timeline Started 2004-04 · est. completion 2004-06
Where 1 site · Germany
What this study is testing ClinicalTrials.gov NCT01507337 ↗
Description as written by the study sponsor.
This trial is conducted in Europe. The aim of this trial is to compare the exposure of liraglutide in young versus elderly healthy subjects.
Treatments tested
- liraglutide Drug
A single dose of 1 mg administered subcutaneously (under the skin)
| Main thing measured | Area under the liraglutide plasma concentration time curve (AUC 0-t) |
|---|---|
| Sponsor | Novo Nordisk A/S |
| Conditions studied | Diabetes, Healthy |
| GLP-1 drugs | liraglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01507337 ↗